Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
Introduction: Up to 40% of Parkinson’s disease patients taking dopamine agonist medication develop impulse control behaviors which can have severe negative consequences. The current study aimed to utilize dopamine genetics to identify patients most at risk of developing these behaviors. Methods: Dem...
Main Authors: | Alison Hall, Samuel R. Weaver, Lindsey J. Compton, Winston D. Byblow, Ned Jenkinson, Hayley J. MacDonald |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Clinical Parkinsonism & Related Disorders |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590112521000256 |
Similar Items
-
Impulse control disorders and use of dopamine agonists in early onset Parkinson’s disease
by: Pierpaolo Turcano, et al.
Published: (2024-05-01) -
Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists
by: Mohammad Edrees Mohammad, et al.
Published: (2021-01-01) -
Impulse control and related behavioral disorders (ICRD) in Idiopathic Parkinson’s Disease treated with different dopamine agonists in Hong Kong: Is any dopamine agonist better?
by: Hiu Fung Wu, et al.
Published: (2024-01-01) -
Impulse Control Disorders in Parkinson’s Disease and Atypical Parkinsonian Syndromes—Is There a Difference?
by: Mateusz Toś, et al.
Published: (2024-02-01) -
Maladaptive Reward-Learning and Impulse Control Disorders in Patients with Parkinson’s Disease: A Clinical Overview and Pathophysiology Update
by: Jee-Young Lee, et al.
Published: (2014-10-01)